Detection and monitoring of minimal residual disease in acute megakaryoblastic leukemia in children
Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia (AML), which is associated with poor prognosis for all patients except children with t(1;22) or Down syndrome. The frequency of complete remission in case of AMKL is comparable to the frequency of complete remission i...
Guardado en:
Autores principales: | Alexandra D. Palladina, Aleksandr V. Popa, Timur T. Valiev, Valentin G. Nikitaev, Olga A. Chernysheva, Natalia A. Kupryshina, Irina N. Serebryakova, Tamara V. Shvedova, Konstantin L. Kondratchik, Nikolai N. Tupitsyn |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da34523d644c47bfa0efb92a4a548e46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia
por: Christian M. Vonk, et al.
Publicado: (2021) -
ACUTE MEGACARYOBLASTIC LEUKEMIA IN CHILDREN: DIAGNOSTICS AND MRD MONITORING
por: Aleksandra Palladina, et al.
Publicado: (2021) -
Strategies for minimal residual disease detection: current perspectives
por: Andreani G, et al.
Publicado: (2019) -
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
por: Natasha Honoré, et al.
Publicado: (2021) -
Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
por: Brittany M. Smith, et al.
Publicado: (2021)